COMPANY DIRECTORY

Directors

Mr Robert W Moses (Chairman)
Mr Mark Diamond (Managing Director)
Dr Chris Belyea
Dr Frank Bennett
Prof Graham Mitchell

Prof George Werther

Company Secretaries

Mr Phillip Hains

Ms Kate Plumridge
 

Company

Antisense Therapeutics Limited

ACN  095 060 745

Registered Office

Level 1, 10 Wallace Avenue, Toorak, Victoria, 3142

Telephone:  +61 3 9827 8999

Principal Administrative Office & Mailing Address

6 Wallace Avenue, Toorak, Victoria, 3142

Telephone:  +61 3 9827 8999

Facsimile:    +61 3 9827 1166

Bankers

Commonwealth Bank of Australia, Melbourne, Victoria

Auditors

Ernst & Young

8 Exhbition Street
Melbourne,  Victoria,  3000

Solicitors

Minter Ellison

Rialto Towers, Level 23, 525 Collins Street, Melbourne, Victoria, 3000

Share Register

Computershare Investor Services Pty Limited

Yarra Falls, 452 Johnston Street, Abottsford, Victoria, 3067

Telephone:  (03) 9415 5000

Australian Stock Exchange

Antisense Therapeutics Limited shares are quoted on the Australian Stock Exchange.

ASX Code:  ANP

American Depository Receipts (ADR) Information

Antisense Therapeutics Limited has established a Level 1 ADR Program.  The ADRs trade in the US over-the-counter (OTC) market.  Details are as follows:

Ratio:       1 ADR = 20 ordinary shares

Symbol:   ATHJY

CUSIP:     037183100

Website

www.antisense.com.au